Edgewise Therapeutics, Inc. (EWTX)
30.44
+0.78
(+2.63%)
USD |
NASDAQ |
Feb 27, 16:00
30.15
-0.29
(-0.95%)
Pre-Market: 09:12
Edgewise Therapeutics Total Assets (Quarterly) : 552.60M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Glaukos Corp. | 930.37M |
| Nuvalent, Inc. | 1.413B |
| Neurocrine Biosciences, Inc. | 4.753B |
| Omeros Corp. | 185.71M |
| Agios Pharmaceuticals, Inc. | 1.297B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.35M |
| Shareholders Equity (Quarterly) | 522.26M |
| Debt to Equity Ratio | 0.0076 |
| Current Ratio | 19.85 |
| Net Debt Paydown Yield | 0.00% |